Figure 2.
Cumulative incidence of relapse, PFS, and OS in patients with DLBCL and HGBCL receiving prophylactic HDMTX.

Cumulative incidence of relapse, PFS, and OS in patients with DLBCL and HGBCL receiving prophylactic HDMTX.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal